CANTARINI, LUCA
 Distribuzione geografica
Continente #
NA - Nord America 39.030
EU - Europa 31.843
AS - Asia 18.638
SA - Sud America 3.524
Continente sconosciuto - Info sul continente non disponibili 1.673
AF - Africa 1.191
OC - Oceania 74
AN - Antartide 1
Totale 95.974
Nazione #
US - Stati Uniti d'America 38.403
GB - Regno Unito 7.350
IT - Italia 7.087
RU - Federazione Russa 5.936
SG - Singapore 5.882
CN - Cina 5.539
IE - Irlanda 2.967
BR - Brasile 2.914
VN - Vietnam 2.007
UA - Ucraina 1.670
HK - Hong Kong 1.604
FR - Francia 1.561
DE - Germania 1.552
SE - Svezia 1.429
FI - Finlandia 1.064
KR - Corea 988
BD - Bangladesh 715
ZA - Sudafrica 676
IN - India 524
CA - Canada 319
NL - Olanda 315
AR - Argentina 213
TR - Turchia 208
IQ - Iraq 191
PL - Polonia 190
JP - Giappone 187
MX - Messico 154
ES - Italia 147
PK - Pakistan 109
CI - Costa d'Avorio 104
EC - Ecuador 99
ID - Indonesia 98
AT - Austria 90
NG - Nigeria 83
CZ - Repubblica Ceca 78
KE - Kenya 78
VE - Venezuela 74
BE - Belgio 73
AU - Australia 66
UZ - Uzbekistan 65
MA - Marocco 62
SA - Arabia Saudita 61
CL - Cile 60
CH - Svizzera 58
CO - Colombia 57
IR - Iran 46
EG - Egitto 45
AE - Emirati Arabi Uniti 43
MY - Malesia 40
DZ - Algeria 37
NP - Nepal 37
PH - Filippine 35
JO - Giordania 34
LT - Lituania 34
PE - Perù 33
JM - Giamaica 31
CR - Costa Rica 28
PY - Paraguay 28
IL - Israele 27
TN - Tunisia 27
KZ - Kazakistan 26
RO - Romania 25
UY - Uruguay 24
DK - Danimarca 22
GR - Grecia 22
BG - Bulgaria 20
BY - Bielorussia 20
LB - Libano 20
AL - Albania 17
AZ - Azerbaigian 16
BO - Bolivia 16
ET - Etiopia 16
EU - Europa 16
HU - Ungheria 16
PT - Portogallo 16
PA - Panama 15
OM - Oman 14
SN - Senegal 14
TT - Trinidad e Tobago 14
EE - Estonia 13
SV - El Salvador 13
HN - Honduras 12
LV - Lettonia 12
TW - Taiwan 12
BH - Bahrain 11
DO - Repubblica Dominicana 11
TH - Thailandia 11
KG - Kirghizistan 10
PS - Palestinian Territory 10
CY - Cipro 9
NO - Norvegia 9
AM - Armenia 8
RS - Serbia 8
SC - Seychelles 8
BB - Barbados 7
GE - Georgia 7
HR - Croazia 7
LY - Libia 7
MK - Macedonia 7
QA - Qatar 7
Totale 94.180
Città #
Southend 6.689
Dallas 5.964
Singapore 3.549
Fairfield 3.337
Dublin 2.923
Ashburn 2.807
Santa Clara 1.931
Milan 1.841
Chandler 1.704
Moscow 1.632
Woodbridge 1.582
Hong Kong 1.510
San Jose 1.497
Wilmington 1.357
Houston 1.350
Jacksonville 1.329
Council Bluffs 1.310
Hefei 1.294
Seattle 1.294
Beijing 1.173
Cambridge 1.124
Seoul 971
Siena 859
Ann Arbor 840
Rome 699
Los Angeles 680
The Dalles 675
Menlo Park 655
Helsinki 628
Johannesburg 619
Ho Chi Minh City 594
New York 579
Princeton 537
Lauterbourg 508
Hanoi 487
Munich 462
Nanjing 454
Columbus 290
Buffalo 286
São Paulo 268
Boardman 258
Florence 243
San Mateo 232
San Diego 205
Bengaluru 177
Düsseldorf 172
Chicago 161
Dong Ket 161
Figino 160
Orem 155
Nanchang 141
London 138
Redondo Beach 136
Frankfurt am Main 135
Shenyang 126
Warsaw 122
Turin 121
Shanghai 117
Tokyo 109
Abidjan 104
Dearborn 101
Turku 100
Rio de Janeiro 95
Naples 94
Nuremberg 92
Lappeenranta 89
Toronto 88
Brooklyn 87
Washington 86
Changsha 85
Montreal 85
Tianjin 85
Da Nang 84
Chennai 83
Haiphong 82
Abuja 80
Bologna 80
Guangzhou 78
San Francisco 78
Boston 73
Atlanta 72
Hebei 68
Baghdad 67
Jiaxing 67
Denver 65
Belo Horizonte 64
Phoenix 64
Stockholm 61
Jinan 60
Brussels 57
Amsterdam 56
Izmir 56
Tashkent 55
Manchester 52
Norwalk 52
Portsmouth 52
Kunming 51
Mexico City 51
Venezia 51
Bari 50
Totale 64.357
Nome #
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases 914
A first update on mapping the human genetic architecture of COVID-19 601
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 592
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 534
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 508
Genetic mechanisms of critical illness in COVID-19 452
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 440
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 413
Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS) 393
An explainable model of host genetic interactions linked to COVID-19 severity 386
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 382
Pathogen-sugar interactions revealed by universal saturation transfer analysis 373
Eosinophilia-associated muscle disorders:an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms 368
Antirheumatic agents in covid-19: is IL-6 the right target? 368
Antiangiogenic VEGF isoform in inflammatory myopathies 366
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 365
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 357
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 355
Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study 352
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 347
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis 340
A Novel Ultrasonographic Anthropometric-Independent Measurement of Median Nerve Swelling in Carpal Tunnel Syndrome: The "Nerve/Tendon Ratio" (NTR) 333
A case of amyloid myopathy in a patient with familial Mediterranean fever 328
Dry eye disease and spondyloarthritis: expanding the spectrum of systemic inflammatory disorders associated with ocular surface disease. Data from the international AIDA Network Spondyloarthritis Registry 327
Mapping the human genetic architecture of COVID-19 325
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 323
Peripheral biomarkers' panel for severe COVID-19 patients 323
The purinergic P2×7 receptor is expressed on monocytes in Behçet's disease and is modulated by TNF-α 322
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 322
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 321
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 320
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 319
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 313
Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry 310
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 309
Colchicine myopathy and neuromyopathy: two cases with different characteristics 308
POS0871 diagnostic accuracy og power doppler ultrasonography for the diagnosis of idiopathic inflammmatory myopathies 305
A case of resistant adult-onset periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome responsive to anakinra. 304
Carriers of ADAMTS13 Rare Variants Are at High Risk of Life-Threatening COVID-19 302
Biological treatments: new weapons in the management of monogenic autoinflammatory disorders 302
Accuracy of power Doppler ultrasonography in the diagnosis and monitoring of idiopathic inflammatory myopathies 298
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 298
Validation of a diagnostic score for the diagnosis of autoinflammatory diseases in adults 296
Efficacy and safety of canakinumab in patients with Still's disease: exposure-response analysis of pooled systemic juvenile idiopathic arthritis data by age groups 295
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 287
Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis 285
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 284
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 281
Certolizumab Pegol treatment in Behcet’s disease with different organ involvement: a multicenter retrospective observational study 281
Eosinophils in inflammatory muscle disorders: a morphologic and immunohistological study. 280
A national cohort study on pediatric Behçet's disease: Cross-sectional data from an Italian registry 277
Clodronate in the management of different musculoskeletal conditions 275
Behçet’s syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 275
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 273
Bone status of children born from mothers with autoimmune diseases treated during pregnancy with prednisone and/or low molecular weight heparin 273
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 272
The 2014 ACR annual meeting: a bird's eye view of autoimmunity in 2015 271
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: An observational multicentre study 270
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 266
Effects of tumor necrosis factor-α inhibitors in mothers and daughters concordant for HLA-B27-positive ankylosing spondylitis 265
Challenges and new horizons in the periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome 265
EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria 264
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 263
Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease 262
SAT0564 Articular Involvement in Behçet Disease: An Ultrasonographic Study 260
Gain- and Loss-of-Function CFTR Alleles Are Associated with COVID-19 Clinical Outcomes 260
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 258
Mechanisms of action of spa therapies in rheumatic diseases: what scientific evidence is there? 254
Safety and efficacy of etanercept in children with juvenile-onset Behcets disease 253
Therapeutic effect of spa therapy and short wave therapy in knee osteoarthritis: a randomized, single blind, controlled trial 251
Autoinflammatory disorders and patients with isolated serosal involvement. 249
Treatment options for periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome in children and adults: a narrative review 249
Weekly oral alendronate in mevalonate kinase deficiency 248
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 248
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 247
A novel grey scale and Power Doppler ultrasonographic score for idiopathic inflammatory myopathies: Siena Myositis Ultrasound Grading Scale 246
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 246
The eye involvement in monogenic autoinflammatory diseases: Literature review and update 246
First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS). 244
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 244
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 244
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 244
Recommendations for the management of autoinflammatory diseases 242
AB0611 Neutrophil extracellular traps and interstitial lung disease in ANCA-associated vasculitis: a scoping review 240
Macrophage activation syndrome in the course of monogenic autoinflammatory disorders 240
Efficacy and Safety of Adalimumab in Behçet’s disease related uveitis: a multicenter retrospective observational study 240
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry 239
Development and implementation of the AIDA international registry for patients with non-infectious uveitis 236
Diagnostic criteria for adult-onset periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome 236
Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes 235
Drug retention rates and treatment discontinuation among anti-TNF-α agents in psoriatic arthritis and ankylosing spondylitis in clinical practice 235
Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease 235
Effect of hyaluronic acid (MW 500-730 kDa) on proteoglycan and nitric oxide production in human osteoarthritic chondrocyte cultures exposed to hydrostatic pressure 235
Doppler and Spectral Ultrasound of Sacroiliac Joints in Pediatric Patients with Suspected Juvenile Spondyloarthritis 234
Clinical and biochemical landmarks in systemic autoinflammatory diseases 233
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 233
IL-6 blockade in the management of non-infectious uveitis 232
COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs 232
Biological treatments in Behçet's disease: beyond anti-TNF therapy 231
A patient-driven registry on Behçet’s disease: the AIDA for patients pilot project 230
Totale 30.607
Categoria #
all - tutte 279.486
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 279.486


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.588 0 567 335 334 286 183 227 204 365 627 508 952
2022/20236.237 407 417 733 884 616 1.259 238 501 650 135 244 153
2023/20245.263 236 162 480 278 229 1.332 1.531 206 43 161 163 442
2024/202514.742 600 710 1.543 802 1.633 826 654 832 1.018 708 1.488 3.928
2025/202636.703 2.531 5.405 4.522 4.072 5.882 1.536 3.751 1.365 1.309 1.781 1.275 3.274
2026/20273.013 1.901 1.112 0 0 0 0 0 0 0 0 0 0
Totale 95.974